Steward Partners Investment Advisory’s Indaptus Therapeutics INDP Stock Holding History

Steward Partners Investment Advisory’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1	Closed	–	–	3417
2022 Q3	$0	Hold	1	–	–	﹤0.01%	3304
2022 Q2	$0	Hold	1	–	–	﹤0.01%	3305
2022 Q1	$0	Hold	1	–	–	﹤0.01%	3326
2021 Q4	$0	Hold	1	–	–	﹤0.01%	3250
2021 Q3	$0	Hold	1	–	–	﹤0.01%	3243
2021 Q2	$0	Hold	1	–	–	﹤0.01%	7241
2021 Q1	$481	Hold	1	–	–	﹤0.01%	3353
2020 Q4	$0	Sell	1 -5	-83%	-$2.18K	﹤0.01%	2936
2020 Q3	$3K	Hold	6	–	–	﹤0.01%	2496
2020 Q2	$4K	Buy	6 +2	+50%	+$1.24K	﹤0.01%	2325
2020 Q1	$1K	Hold	4	–	–	﹤0.01%	2385
2019 Q4	$4K	Hold	4	–	–	﹤0.01%	2302
2019 Q3	$6K	Buy	4 +2	+100%	+$5.95K	﹤0.01%	2192
2019 Q2	$19K	Buy	+2	New	+$25.2K	﹤0.01%	1726

Other funds holding INDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $1.92B AUM 25.81% 1-Year Est. Return

SAM

Strategy Asset Managers Pasadena, California $609M AUM 32.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

VCM

Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Steward Partners Investment Advisory's INDP Position: Q4 2022 in Review

Steward Partners Investment Advisory sold out of Indaptus Therapeutics (INDP) in Q4 2022, closing a stake of 1 share.

Steward Partners Investment Advisory first reported a position in INDP in Q2 2019 and held it in 14 quarters. The position peaked at $19K in Q2 2019. 16 funds tracked by Wall St. Rank hold INDP as of Q4 2022.

Steward Partners Investment Advisory reported no remaining Indaptus Therapeutics position as of Q4 2022 after selling out during the quarter.
Steward Partners Investment Advisory sold 1 Indaptus Therapeutics share in Q4 2022.
Steward Partners Investment Advisory first reported a position in Indaptus Therapeutics in Q2 2019 and held it in 14 quarters.
Steward Partners Investment Advisory's Indaptus Therapeutics position peaked at $19K in Q2 2019.
16 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q4 2022.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2022, filed 15 Feb 2023.